RxSight, Inc. (RXST)

NASDAQ: RXST · USD

$4.88

-0.02 (-0.4%)· Recorded snapshot

Market cap	203M
Revenue (ttm)	127.6M
Net income (ttm)	-46.9M
EPS (ttm)	-$1.14
Shares out	41.6M
Volume	608,869
Beta	1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 127.6M
Net income (ttm): -46.9M
EPS (ttm): -$1.14
Market cap: 203M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-17.3

P25 n/aP50 n/aP75 n/a

ROIC-87.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All RXST indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001111485
Company name	RxSight, Inc.
Country	United States
Country code	US
CUSIP number	78349D107
Earnings date	2026-11-03
Earnings time	amc
Employees	461
Employees change	-37
Employees growth	-7.43%
Enterprise value	$4.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1997
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2021-07-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US78349D1072
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$203M
Market cap category	Micro-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$4.88
Price currency	USD
Sector	Healthcare
SIC code	3851
Stock price date	2026-10-28
Symbol	RXST
U.S. state	California
Website	https://rxsight.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-23.33%
EV/Sales	0x
FCF / EV yield	-4,552.05%
FCF yield	-13.66%
Forward EV/Sales	0x
Forward P/S	1.26x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.77x
P/S ratio	1.56x
Price / tangible book value	0.75x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-43.2%
EBITDA margin	-40.42%
Gross margin	77.5%
Operating margin	-43.2%
Pretax margin	-36.71%
Profit margin	-36.8%
Profit per employee	$-101,842
Revenue per employee	$276,751
ROA	-10.41%
ROA (5Y)	-16.63%
ROCE	-20.24%
ROE	-17.35%
ROE (5Y)	-56.71%
ROIC	-87.93%
ROIC (5Y)	-129.94%
SBC / revenue	24.56%
Tax / revenue	0.09%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-8.05%
Gross profit growth (Q)	2.76%
Gross profit growth 3Y	41.15%
Gross profit growth 5Y	110.24%
Net income growth years	0
Revenue growth	-13.24%
Revenue growth (Q)	0.31%
Revenue growth (QoQ)	9.22%
Revenue growth 3Y	23.95%
Revenue growth 5Y	48.84%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4.4M
Depreciation and amortization	$3.5M
EBIT	$-55.1M
EBITDA	$-51.6M
EPS	$-1.14
FCF per share	$-0.65
Financing cash flow	$859,000
Free cash flow	$-27.2M
Free cash flow minus SBC	$-58.5M
Gross profit	$98.9M
Income taxes	$110,000
Investing cash flow	$-5.1M
Net borrowing	$-24,000
Net cash flow	$-27M
Net income	$-46.9M
Operating cash flow minus SBC	$-54.1M
Operating income	$-55.1M
Revenue	$127.6M
Stock-based compensation	$31.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.24
Book value per share	$6.33
Debt / equity	0.04
Interest coverage	-3,936.64
Long-term assets	$25.3M
Long-term liabilities	$8.9M
Net cash (debt)	$198.2M
Net cash / market cap	99.7%
Net cash growth	-8.14%
Net debt / equity	-0.75
Piotroski F-Score	2
Property, plant and equipment	$23.5M
Shareholders' equity	$263.3M
Tangible book value	$263.3M
Tangible book value per share	$6.33
Total assets	$352.7M
Total cash	$208.8M
Total debt	$10.6M
Total liabilities	$89.4M
WACC	10.01%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	$327.4M
Current liabilities	$80.4M
Current ratio	4.07
Inventory turnover	0.92
Net working capital	$39.8M
Quick ratio	3.57
Working capital	$247M
Working capital turnover	0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.18%
Dividend yield	0%
Shareholder yield	-2.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.80
1D price change	-0.41%
1M price change	3.65%
1M total return	3.65%
1W price change	-1.02%
1W total return	-1.02%
1Y price change	-44.23%
1Y return CAGR	-44.25%
1Y total return	-44.23%
20-day SMA	$4.77
200-day SMA	$6.41
3M price change	-14.36%
3M total return	-14.36%
3Y price change	-77.31%
3Y return CAGR	-39%
3Y total return	-77.31%
50-day SMA	$5.44
50-day SMA vs 200-day SMA	50under200
52-week high	$13.22
52-week high date	2025-12-11
52-week low	$4.40
52-week low date	2026-10-14
5Y price change	-59.72%
5Y return CAGR	-16.63%
5Y total return	-59.72%
6M price change	-33.74%
6M total return	-33.74%
All-time high	$66.54
All-time high date	2024-05-07
All-time low	$4.40
All-time low date	2026-10-14
Average true range (ATR)	$0.24
Average volume	621K
Beta (1Y)	0.7
Beta (2Y)	1.23
Beta (5Y)	1.14
Change from 52-week high	-63.09%
Change from 52-week low	10.91%
Change from all-time high	-92.74%
Change from all-time low	9.77%
Change from open	0.41%
Day's gap	-0.82%
Dollar volume	$3M
High price	$4.94
Low price	$4.75
Monthly RSI	33.96
Open price	$4.86
Position in 52-week range	70.27%
Premarket change	-2.65%
Premarket close	$4.90
Premarket price	$4.77
Previous close	$4.90
Price vs 150-day SMA	-16.74%
Price vs 20-day SMA	1.24%
Price vs 200-day SMA	-24.7%
Price vs 50-day SMA	-11.2%
Relative volume	0.98
Return from IPO open	-72.69%
Return from IPO price	-70.13%
RSI	45.17
Sharpe ratio	-0.69
Sharpe ratio (3Y)	-0.51
Sharpe ratio (5Y)	0.02
Sortino ratio	-0.89
Sortino ratio (3Y)	-0.6
Sortino ratio (5Y)	0.11
Volume	608.9K
Weekly RSI	40.78
YTD price change	-53.65%
YTD total return	-53.65%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33.7M
Float percentage	81.04%
Shares change (QoQ)	0.45%
Shares change (YoY)	2.18%
Shares held by insiders	5.7%
Shares held by institutions	91.57%
Shares outstanding	41.6M
Short % of float	12.13%
Short % of shares	9.83%
Short ratio	4.9 days

Deeper analysis on RXST

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this RXST report

Is a complete RXST research report available?

No complete published report is available for RxSight, Inc. (RXST) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

RxSight, Inc. (RXST)

Price

Financial snapshot

Fair-value bridge

Latest news · RXST

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RXST indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RXST

Frequently asked questions